Emergent BioSolutions Inc. (EBS), based in Gaithersburg, Maryland, is a prominent life sciences company specializing in vaccines, therapeutics, and diagnostics that bolster public health preparedness. The firm is integral in combating urgent health threats such as emerging infectious diseases and bioterrorism, offering advanced solutions suited for both civilian and military applications. With a steadfast commitment to health security and a strategic focus on responding to global health emergencies, Emergent is well-positioned to enhance governmental response capabilities and strengthen the resilience of public health systems on a global scale. Show more

Location: 300 PROFESSIONAL DRIVE, GAITHERSBURG, MD, UNITED STATES, 20879, Gaithersburg, MD, 20879, USA | Website: https://www.emergentbiosolutions.com | Industry: DRUG MANUFACTURERS - SPECIALTY & GENERIC | Sector: HEALTHCARE


Market Cap

605M

52 Wk Range

$4.02 - $14.06

Previous Close

$11.90

Open

$11.71

Volume

566,876

Day Range

$11.29 - $12.05

Enterprise Value

1.043B

Cash

245.5M

Avg Qtr Burn

-2.30M

Insider Ownership

2.75%

Institutional Own.

76.92%

Qtr Updated

09/30/25


Only showing assets and stage. See catalyst data with a free or premium account. Unlock more data with a free account.

Drug & IndicationStage & EventCatalyst Date

Approved

Update

Approved

Update

Approved

Quarterly sales

Approved

Quarterly sales

Approved

Quarterly sales

Approved

Quarterly sales

Approved

Quarterly sales

Failed

Discontinued

Failed

Discontinued

Failed

Discontinued

CHIKV VLP Details
Chikungunya, Viral infection

Failed

Discontinued